Drug: Oxycodone/Naloxone: chronic pain clinical trials
Registry records that list "Drug: Oxycodone/Naloxone" as an intervention. Being studied does not mean an intervention works or is approved.
0
Trials with Canadian sites
0
Recruiting in Canada
5
Registry records in total
Trials in Canada
No trial with a Canadian site lists this intervention in this snapshot.
Trials worldwide (outside Canada)
5 trials, 0 recruiting or not yet recruiting. Recruiting first.
| Phase | Countries | ||||
|---|---|---|---|---|---|
| Determine the Safety and Efficacy of Oxy/Nal Tablets Compared to Oxy PR in Subjects With Cancer Pain NCT01885182 | Completed | Phase 3 | China | Mundipharma (China) Pharmaceutical Co. Ltd | 2013-06-01 |
| Treatment of Chronic Pain From Osteoarthritis NCT02032927 | Withdrawn | Phase 4 | Italy | Fondazione IRCCS Policlinico San Matteo di Pavia | 2013-06 |
| An Interventional Study to Compare the Efficacy and Tolerability With Targin® in Non-malignant Chronic Pain (GLORY) NCT01811186 | Completed | Phase 4 | South Korea | Mundipharma Korea Ltd | 2012-12 |
| A Study to Compare Oxycodone/Naloxone Prolonged Release Against Codeine/Paracetamol in the Treatment of Moderate to Severe Chronic Low Back Pain or Pain Due to Osteoarthritis NCT00784810 | Completed | Phase 4 | United Kingdom | Napp Pharmaceuticals Limited | 2009-02 |
| A Study Comparing Oxycodone to Oxycodone/Naloxone in Moderate to Severe, Chronic Cancer Pain NCT00513656 | Completed | Phase 2 | United Kingdom | Mundipharma Research GmbH & Co KG | 2007-09 |
Conditions studied with this intervention
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status.